A Global Virtual Network for foot-and-mouth disease in case of emergency

Developments in Biologicals

Volumn 119, Issue , 2005, Pages 317-331

  Palma, E L ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Antigen banks; Emergency vaccination; Foot and mouth disease; Vaccine banks network; Virtual network

Indexed keywords

VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; AUSTRALIA; DRUG STORAGE; EMERGENCY; EMERGENCY TREATMENT; EPIDEMIC; FOOT AND MOUTH DISEASE; IMMUNOLOGY; INTERNATIONAL COOPERATION; METHODOLOGY; REVIEW;

ANIMALS; AUSTRALIA; DISEASE OUTBREAKS; DRUG STORAGE; EMERGENCIES; EMERGENCY TREATMENT; FOOT-AND-MOUTH DISEASE; INTERNATIONAL COOPERATION; VIRAL VACCINES;

EID: 20344389546     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (21)

1. th edition, Paris, France: Office International des Epizooties, 2001.
2. Forman AJ, Garland AJM: Foot and mouth disease: the future of vaccine banks. Rev Sci Tech Off Int Epiz 2002;21:601-612.
3. Barnett PV, Staham RJ: Stratified and cryogenically stored (SACS) vaccines, a new concept in emergency foot-and-mouth disease vaccine formulation and storage. Vaccine 2002;20:2060-2064.
4. Lombard MF, Dubourget PG, Schumacher CL: Strategic reserves, advantages and disadvantages: the manufacturer's experience, in Dodet B, Vicari M (eds): Foot-and-Mouth Disease: Control Strategies, 2003, pp 221-231.
5. th Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), 9-11 April, Rome. EUFMD, Rome, Appendix 2003;13:136-143.
6. nd General Session of the Office International des Epizooties (OIE), 16-20 May, Paris. OIE, Paris, Report 62/SG 1994;10:1-6.
7. Anon: (a) Foot and Mouth Disease Profilaxis in Europe 1991-92.
8. th Session of the European Commission for the Control of Foot and Mouth Disease, Rome, Italy, 27-30 April 1993, Appendix 3, 28-35.
9. st Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), Rome, 5-7 April, 1995, Appendix 9, 60-65.
10. nd Session of the European Commission for the Control of Foot and- Mouth Disease (EUFMD),Rome, 2-4 April, 1997, Appendix 8, 89-111.
11. rd Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), Rome, 7-9 April, 1999, Appendix 18, 154-165.
12. th Session of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD), Rome, 21-23 March, 2001, Appendix 12, 117-127.
13. Leforban Y: How predictable were the outbreaks of foot-and-mouth disease in Europe in 2001 and is vaccination the answer? Rev Sci Tech Off Int Epiz 2002;21:549-556.
14. Tami C, Taboga O, Berinstein A, Núñez JI, Palma E, Sobrino F, Domingo E, Carrillo E: Evidence of coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo. J Virology 2003;77:1219-1226.
15. Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, Holmes EC: Unifying the epidemiological and evolutionary dynamic of pathogens. Science 2004;303:327-332.
16. Doel TR: Foot-and-mouth disease: vaccine strains and field isolates, in Dodet B, Vicari M (eds): Foot and Mouth Disease Control Strategies. 2003, pp 287-296.
17. Barnett PV, Samuel AR, Statham RJ: The suitability of the 'emergency' foot and mouth disease antigens held by the International Vaccine Bank within a global context. Vaccine 2001;19:2107-2117.
18. Paton DJ, Ferris N, Knowles N, Turner L, Statham R: WRL report: FMD global situation. Proposed priority antigens for 2003-2004. Where are the information gaps? In Reports of the Session of the Research Group of the Standing Technical Committee of EUFMD, 16-19 September, Gerzensee, Berne, Switzerland, 2003, Appendix 8, 63-70.
19. Smitsaart E, Mattion N, Mazzuca G, Robiolo B, Maradei E, Filippi J, Sadir A, Falczuk A, La Torre J, Pedemonte A, D'aloia R, Periolo O, Cadenazzi G, Palma E, Bellinzoni R: Foot-and-mouth disease in Argentina: development of vaccines for emergency, control and eradication of the disease. In Reports of the Session of the Research Group of the Standing Technical Committee of EUFMD, 17-20 September, Cesme, Izmir, Turkey, 2002, Appendix 40, 336-348.
20. Füssel AE: Strategic reserves of FMD vaccines: the EC point of view, in Dodet B, Vicari M (eds): Foot and Mouth Disease Control Strategies. 2003, pp 213-219.
21. De Clercq K, Paton D: FMD research initiatives and future needs. In Reports of the Session of the Research Group of the Standing Technical Committee of EUFMD, 16-19 September, Gerzensee, Berne, Switzerland, 2003, Appendix 1, 23-31.